Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Research Articles, Behavioral/Cognitive

Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific

Jolande Fooken, Pooja Patel, Christina B. Jones, Martin J. McKeown and Miriam Spering
Journal of Neuroscience 19 January 2022, 42 (3) 487-499; https://doi.org/10.1523/JNEUROSCI.1690-21.2021
Jolande Fooken
1Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada K7L 3N6
2Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pooja Patel
2Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina B. Jones
5Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada V6T 2B5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. McKeown
3Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
4Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
5Medicine, Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada V6T 2B5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam Spering
2Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
3Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
4Djavad Mowafaghian Center for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
6Institute for Computing, Information and Cognitive Systems, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Parkinson's disease (PD) is a neurodegenerative disease that includes motor impairments, such as tremor, bradykinesia, and postural instability. Although eye movement deficits are commonly found in saccade and pursuit tasks, preservation of oculomotor function has also been reported. Here we investigate specific task and stimulus conditions under which oculomotor function in PD is preserved. Sixteen PD patients and 18 healthy, age-matched controls completed a battery of movement tasks that included stationary or moving targets eliciting reactive or deliberate eye movements: pro-saccades, anti-saccades, visually guided pursuit, and rapid go/no-go manual interception. Compared with controls, patients demonstrated systematic impairments in tasks with stationary targets: pro-saccades were hypometric and anti-saccades were incorrectly initiated toward the cued target in ∼35% of trials compared with 14% errors in controls. In patients, task errors were linked to short latency saccades, indicating abnormalities in inhibitory control. However, patients' eye movements in response to dynamic targets were relatively preserved. PD patients were able to track and predict a disappearing moving target and make quick go/no-go decisions as accurately as controls. Patients' interceptive hand movements were slower on average but initiated earlier, indicating adaptive processes to compensate for motor slowing. We conclude that PD patients demonstrate stimulus and task dependency of oculomotor impairments, and we propose that preservation of eye and hand movement function in PD is linked to a separate functional pathway through the superior colliculus-brainstem loop that bypasses the fronto-basal ganglia network. Our results demonstrate that studying oculomotor and hand movement function in PD can support disease diagnosis and further our understanding of disease progression and dynamics.

SIGNIFICANCE STATEMENT Eye movements are a promising clinical tool to aid in the diagnosis of movement disorders and to monitor disease progression. Although Parkinson's disease (PD) patients show some oculomotor abnormalities, it is not clear whether previously described eye movement impairments are task-specific. We assessed eye movements in PD under different visual (stationary vs moving targets) and movement (reactive vs deliberate) conditions. We demonstrate that PD patients are able to accurately track moving objects but make inaccurate eye movements toward stationary targets. The preservation of eye movements toward dynamic stimuli might enable patients to accurately act on the predicted motion path of the moving target. These results can inform the development of tools for the rehabilitation or maintenance of functional performance.

  • eye movements
  • Parkinson's disease
  • prediction
  • preservation of function
  • saccades
  • smooth pursuit

Introduction

Eye movements are increasingly used as a clinical tool to enable earlier diagnosis (Marx et al., 2012) and to assess disease progression and treatment effects (Patel et al., 2019) in patients with Parkinson's disease (PD). Cardinal motor symptoms in PD patients include tremor, bradykinesia, and postural instability, but also impairments of oculomotor function (Armstrong, 2008, 2015). Eye movement deficits are especially prevalent when tasks involve higher-level cognitive processing or deliberation, such as remembering the motion path of a target (memory-based pursuit) (Fukushima et al., 2015), anticipating or predicting a future sensory event (predictive pursuit) (Helmchen et al., 2012; Fukushima et al., 2017), or representing more than one concurrent movement goal (double-step task) (Bhutani et al., 2013). Moreover, PD patients show executive task-dependent deficits, for example, when selecting a target among a stream of temporally competing distractors (Zokaei et al., 2021), a process that requires suppressing distracting information, or when inhibiting a movement (anti-saccades) (Chan et al., 2005; Amador et al., 2006; Waldthaler et al., 2021).

Many of the fundamental action-regulating functions required for higher-level tasks are mediated to some degree by the basal ganglia (Jenkinson and Brown, 2011; Noorani and Carpenter, 2014), a brain region profoundly affected by degeneration of dopaminergic neurons in the substantia nigra in PD patients (Albin et al., 1989). Aside from their role in oculomotor control (Hikosaka et al., 2000), the basal ganglia might act as a gateway to sensory and memory function (McNab and Klingberg, 2008), as a performance mediator (Thura and Cisek, 2017), and as a key structure involved in sensory evidence accumulation (Perugini et al., 2018) and cancelation of impending actions (Noorani and Carpenter, 2014). Dopaminergic cortical-basal ganglia circuits are implicated in sensory and cognitive deficits in PD patients, especially in situations that require decision-making (Perugini et al., 2016).

Despite systematic movement deficits, there appears to be some preservation of motor function in PD patients. For example, “Kinesia Paradoxa” refers to the clinical phenomenon that PD patients perform selected sensory-driven motor tasks with near-normal ability, despite general motor slowing (Glickstein and Stein, 1991; Duysens and Nonnekes, 2021). In the oculomotor domain, preserved functions include the latency of visually guided saccades (Briand et al., 1999; Chan et al., 2005) and the initiation of visually driven smooth pursuit (Fukushima et al., 2015), functions that are driven by external, visual stimulation (as opposed to self-generated). During reaching, PD patients are able to reach for a moving ball as quickly as controls, but they are impaired when asked to make a self-generated reach for a stationary ball (Majsak et al., 1998). Preserved functions are also found when a movement trajectory has to be corrected online to account for a displacement of the movement target, a task that requires a sense of urgency (Desmurget et al., 2004). Congruently, PD patients performed corrective saccades at a comparable level to healthy controls in a saccade double-step task (Merritt et al., 2017), although they also exhibited a larger number of averaging saccades (Bhutani et al., 2013). In sum, there is consensus that eye movements can be spared in PD patients under some task and stimulus conditions. This relative preservation of function might allow insights into disease mechanisms and dynamics, and is the focus of the current paper.

Because oculomotor function is inextricably linked to visual and cognitive processes, studying eye movements in PD can help us understand the relationship between cognitive and classic motor symptoms, such as balance or gait. For example, eye movements are known to be closely related to visual perception (Schütz et al., 2011), which is also impaired in PD (Armstrong, 2008, 2015; Ming et al., 2016). Yet, preservation and impairments of eye movements have only recently been studied as a sensitive tool to investigate PD-related cognitive decline (Ouerfelli-Ethier et al., 2018; Stuart et al., 2019), comorbidities such as impulse-control disorders (Barbosa et al., 2019), symptoms of disease progression (Gallea et al., 2021), and treatment effects (Patel et al., 2019). Here, we aim to systematically examine the accuracy, variability, and preservation of oculomotor functions across different stimuli and task demands. The ultimate goals of this study are to provide new insights into the circumstances under which eye movements are impaired or spared, to evaluate the functional significance of eye movement preservation in PD, and to discuss how studying eye movements can aid our understanding of disease progression and dynamics.

We tested 16 PD patients and 18 healthy, age-matched controls on a battery of movement tasks (pro-saccades, anti-saccades, visually guided pursuit, and a rapid go/no-go manual interception task. In these tasks, participants viewed either stationary or moving stimuli that elicited reactive or deliberate eye movements (Fig. 1). The different combinations of stimulus property (stationary vs moving) and eye movement response (reactive vs deliberate) allows us to investigate similarities and differences in saccade and pursuit deficiencies as a function of stimulus and task. PD patients showed systematic impairments in tasks that involved stationary targets, indicating impaired saccade inhibition. By contrast, eye and hand movements to moving targets were generally preserved in PD patients as compared with controls.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Stimulus characteristics and movement requirements in a battery of oculomotor tasks.

Materials and Methods

Participants

Participants were 16 patients with mild to moderate PD (Hoehn and Yahr 1-2) (Goetz et al., 2004) and 18 healthy, age- and sex-matched controls (Table 1). Inclusion criteria for all participants were visual acuity of 20/50 or better, no history of psychiatric or other neurologic disease, including no concussion within the past 2years, no history of ocular motility abnormality, and normal cognitive function (Montreal Cognitive Assessment, score of ≥25; Nasreddine et al., 2005). To ensure near-normal visual acuity, all participants were tested using the Early Treatment of Diabetic Retinopathy Study chart at a 4 m distance (Original Series Chart “R”; Precision Vision). Participants with corrective lenses were asked to wear their glasses or contact lenses during testing. All participants confirmed that they were able to clearly see the visual targets. Patients were recruited through the University of British Columbia Pacific Parkinson's Research Center and affiliated clinical offices and were diagnosed by a neurologist. Controls were recruited from the community. Patients were tested twice, on two different days, once while on medication (Levodopa or equivalent; Table 1), within 2 h of last dose intake, once off medication, after overnight withdrawal of dopaminergic withdrawal; controls were tested once. Testing order for patients (on vs off medication) was randomized. All experimental procedures were aligned with the Declaration of Helsinki and approved by the University of British Columbia Clinical Research Ethics board; participants gave written informed consent.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of study participantsa

Visual display and apparatus

Stimuli were back-projected onto a translucent screen with a PROPixx video projector (VPixx Technologies; refresh rate 60 Hz, resolution 1280 [horizontal] × 1024 [vertical] pixels). The displayed window was 40.7 (horizontal) × 33.3 (vertical) cm or 67 degrees of visual angle [°] × 60° in size. Stimulus display and data collection were controlled by a PC (NVIDIA GeForce GT 430 graphics card), and the experiment was programmed in MATLAB 7.1 using Psychtoolbox 3.0.8 (Brainard, 1997; Pelli, 1997; Kleiner et al., 2007). Participants were seated in a dimly lit room at 46 cm distance from the screen with their head supported by a combined chin and forehead rest.

Saccade and pursuit tasks

Participants first performed a pro- and anti-saccade task (Munoz and Everling, 2004), designed to test saccade control at different levels of deliberation (Fig. 1). Pro- and anti-saccade targets were presented on a black background (0.06 cd/m2). The pro-saccade task (see Fig. 3A) started with a green fixation square (0.8° side length; 69.7 cd/m2) shown at the screen center; eye tracker drift correction was performed during initial fixation. At the same time as the fixation square, two white target squares (each 0.8°; 96.5 cd/m2) were presented in the periphery, at 12° to the left and right of fixation. After a random fixation period (0.8-1.2 s), an open square (1.2° side length) appeared around one of the white target squares, indicating the side to which participants should move their eyes. The offset of the green fixation square served as a cue to initiate a saccade toward the target. The anti-saccade task (see Fig. 4A) followed the same timeline, except that here, the fixation square was red (0.8° side length; 21.6 cd/m2), and the open square marked the distractor (i.e., participants had to look away from it and toward the uncued target). Participants first completed the easier pro-saccade task (1 block of 40 trials) to become familiar with the setup. They were then tested on the anti-saccade task (1 block, 40 trials) without further training.

Participants next performed a sinusoidal smooth pursuit tracking task. This task was designed to characterize basic tracking function akin to testing pursuit at the bedside by regularly moving a small object to-and-fro at different speeds before the patient's eyes (Leigh and Zee, 2015). Each trial started with a drift correction (fixation on a central bull's eye stimulus 2° in diameter). The smooth pursuit target was a small (2° in diameter) black disk presented on a gray background with a luminance of 97.6 candela per meter squared (cd/m2). The target moved sinusoidally for five repetitions at 16°/s or 32°/s, first along the horizontal and then along the vertical meridian (see Fig. 6A). Reflection points were positioned at ± 16° to the left/right or top/down, and each speed was presented once per motion direction resulting in 4 trials per participant.

Track-intercept task

In the second part of testing, participants performed a timed go/no-go task, in which they had to track and manually intercept a moving target that followed a linear-diagonal path and either hit or missed a dedicated strike box (see Fig. 7A). The moving target was a black Gaussian dot (SD = 0.4°; d = 2°; 5.4 cd/m2) presented on a gray background (35.9 cd/m2). The strike box (31.5 cd/m2) was 6° × 10° in size and offset by 12° from the center to the side of interception. Importantly, the target was only shown for 300 or 500 ms and then disappeared. Participants had to predict whether the target would pass or miss the strike box by following the target's assumed trajectory even after it had disappeared. They were asked to intercept the target while it was in the strike box in pass trajectories, and withhold a hand movement in miss trajectories. Each interception started from a table-fixed position and was made with the index finger of the dominant hand. Stimulus velocity followed natural forces (gravity, drag force, Magnus force) (Fooken and Spering, 2019). The target launched at an angle of 5°-12°, depending on the type of trajectory, and moved at a speed of either 13 or 17°/s; conditions were presented in randomized order. Each trial ended when participants either intercepted the target or when the target reached the edge of the screen (2-2.6 s). At the end of each trial, participants received performance feedback; target end position was shown, and correct or incorrect decisions were indicated. Each participant performed a familiarization session (8 trials; full trajectory visible) followed by 120 experimental trials (2 blocks of 60 trials) in which the target viewing time was limited.

Eye and hand movement recordings and preprocessing

Eye position of the right eye was recorded with a video-based eye tracker (Eyelink 1000 tower mount; SR Research) at a sampling rate of 1000 Hz. Eye movements were analyzed offline using custom-made routines in MATLAB (R2015a). Eye velocity profiles were filtered using a low-pass, second-order Butterworth filter with cutoff frequencies of 15 Hz (position) and 30 Hz (velocity). Saccades were detected based on a combined velocity and acceleration criterion: five consecutive frames had to exceed a fixed velocity criterion of 30°/s; saccade onsets and offsets were then determined as acceleration minima and maxima, respectively. Saccades were excluded from smooth pursuit analysis. Pursuit onset was detected in individual traces using a piecewise linear function that was fit to the filtered position trace.

Finger position was recorded with a magnetic tracker (3D Guidance trakSTAR, Ascension Technology) at a sampling rate of 60 Hz; a lightweight sensor was attached to the participant's dominant hand's index fingertip with a small Velcro strap. Finger latency was defined as the first sample in which finger velocity exceeded 5% of the finger's peak velocity. The 2D finger interception position was recorded in x- and y-screen-centered coordinates.

Eye and hand movement performance measures

For all eye and hand movement measures reported in the manuscript, we calculated an average value per participant by finding the median value across trials. We also assessed within-participant variability by calculating the SD of a given measure across trials. We aimed to test patients on two separate visits when they were either on or off their medication (counterbalanced order; Fig. 2). Across all tasks, 3 patients were unable to come in for testing while off medication and 1 patient did not take any medication (P23; Table 1). In addition, we were unable to test one patient (P29) on the sinusoidal pursuit task during their OFF-medication visit, but this patient was tested ON medication (Fig. 2). For the 12 patients that were tested ON and OFF medication, we found no effect of medication on eye movement timing and accuracy in the saccade tasks (e.g., pro-saccade latency, t(11) = 1.93, p = 0.08; anti-saccade error rate, t(11) = 0.04, p = 0.97). Similarly, we found no effect of medication in the 11 patients, who we tested ON and OFF medication in the sinusoidal pursuit task (e.g., eye velocity gain, t(10) = 0.002, p = 0.9983), or for the 9 patients that we had valid datasets for ON and OFF medication visits (see data exclusion below) on sensorimotor decision accuracy (t(8) = 0.12, p = 0.91). Because patients generally had noisier data than controls, we had a higher rate of trial exclusions in patients. Therefore, we decided to pool data from both test days for all patients who came in twice (unless reported otherwise). To ensure that unequal trial numbers across participants did not affect our main results, we repeated each analysis using only data from the first visit. These results did not statistically differ from the results reported here.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Flowchart of participant inclusion by participant group, task, and medication status.

Saccade performance in the pro- and anti-saccade task was quantified by calculating saccade latency, velocity, duration, and amplitude. Saccade latency was defined as the difference between target cue and first saccade onset. Saccades with a latency of <150 ms were defined as express saccades (Fischer, 1987). We then determined the velocity, duration, and 2D amplitude of this initial saccade. For the anti-saccade task, we also calculated the number of direction errors (i.e., saccades directed to the cued rather than uncued target and not later corrected) and the number of changes of mind (i.e., saccades initially directed to the cued target, but then corrected to the uncued target).

Smooth pursuit accuracy was quantified by calculating pursuit latency, gain, position error, and saccade rate. Pursuit latency was defined as the time difference between stimulus onset and pursuit onset. If no pursuit was initiated and participants fixated until initiating a saccade, pursuit onset was defined as the offset of that first saccade. The rate of catch-up saccades was defined as the average number of saccades per second across the entire trial. Pursuit gain, eye position error, and catch-up saccade rate were analyzed during steady-state pursuit, omitting the response within 140 ms of either side of the target deflection points. Gain was defined as the mean relative difference between eye and target velocity; eye position error was defined as the 2D distance between eye and target position. Pursuit gain and eye position error were calculated during smooth tracking (excluding saccades and blinks).

For the track-intercept task, we calculated pursuit latency, initial eye velocity, horizontal position error, and saccade rate while the target was visible (300 or 500 ms), and the latency of the first catch-up saccade. For the finger, we analyzed finger latency, peak velocity, interception timing error, and positional interception error. Finger latency was defined as the difference between target onset and finger movement onset. Interception timing error was calculated by dividing the distance between the target and the point of interception by the average target velocity. Positional interception error was calculated as the 2D error between target position and hand position at time of interception. To calculate hand movement speed adjustment within an experimental session, we used the first session for patients that were tested on and off medication.

All trials were manually inspected and trials, in which participants blinked during target presentation were excluded from analyzing the given task. Based on inspection, we excluded four healthy control participants from the manual interception task that had >25% trials of eye movement signal loss (Fig. 2). Following the same cutoff (>25% of invalid trials), we also excluded data from 1 patient on ON-medication day and data from 2 patients on OFF-medication day for this task, resulting in nine complete ON/OFF datasets, five tested only ON medication, and two tested only OFF medication (Fig. 2). Usable data from the respective other testing days were included in the analysis and pooled across testing days. For the remaining participants, we excluded 132 trials (1%) in the pro-saccade task, 159 trials (1%) in the anti-saccade task, and 575 (12%) in the manual interception task.

Statistical analyses

Differences between PD patients and controls were evaluated using Welch's two-sample unpaired t tests. We used Welch's t tests to adjust for the variance S of each group of size N. Degrees of freedom using Welch t tests are estimated as follows: df=(S2patientsNpatients+S2controlsNcontrols)2(S4patientsN2patients(Npatients−1))+S4controlsN2controls(Ncontrols−1)(1)

Pooled group differences for saccade latency-dependent intervals were compared using a Mann–Whitney test. We assessed the probability of group values being not equal (p value) and the z score (z value). A z value close to 0 indicates that group medians are equal. To compare oculomotor performance across tasks, we calculated a linear regression and correlation coefficient. All statistical analyses were performed using R (version 4.01) (R Core Team, 2017).

Results

Early-stage PD patients with mild to moderate symptoms and age-matched healthy controls performed a variety of movement tasks that required sensorimotor decisions at different levels of task complexity. The tasks ranged from visually guided pro- and anti-saccades, sinusoidal smooth pursuit tracking, to rapid go/no-go manual interceptions.

Eye movements to stationary targets are impaired in PD patients

In the first part of the experiments, participants were instructed to quickly move their eyes either to a stationary target that was cued (pro-saccades) or to a stationary target that was located opposite to a cued distractor (anti-saccades). In both tasks, we found systematic differences in eye movement speed, accuracy, and variability between patients (pooled across ON and OFF medication) and controls. In the pro-saccade task (Fig. 3A), patients tended to undershoot the saccade target on average (i.e., saccades were hypometric), whereas controls landed on the target on average (Fig. 3B). Moreover, patients' saccades were slower (lower peak velocity) compared with controls (Table 2). To investigate whether the velocity reduction in patients' saccades was linked to their saccade hypometria, we considered the relationship between saccade velocity and amplitude (main sequence; Fig. 3C). We found that patients and controls showed a positive linear relationship between saccade velocity and amplitude with comparable slopes (Mpatients = 22.8 ± 5.0 1/s; Mcontrols = 25.0 ± 4.7 1/s; t(32) = 1.33, p = 0.19). These findings indicate that slower saccades in patients could be linked to the fact that their saccades are also of smaller size. Whereas the general relationship between saccade velocity and amplitude was comparable between patients and controls, we found that patients' saccades were more variable across trials (see examples in Fig. 3C). This within-participant eye movement variability was reflected in significantly higher SDs of saccade amplitude, velocity, and latency in patients compared with controls (Table 3).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Sequence of events and eye movements in the pro-saccade task. A, Each trial started with a drift correction followed by a fixation period. Participants had to saccade to the cued target square. B, 2D eye position in pro-saccade task for a representative PD patient (purple) and control participant (green). For illustration purposes, eye and target position data were flipped to always depict the saccade target on the right. C, Main sequence (saccade velocity vs amplitude) for 2 representative patients (purple circles) and 2 control participants (green circles). Each circle represents one trial. D, Saccade latency distributions (relative frequency of binned saccade latencies) for patients and controls. E, Mean saccade amplitude as a function of saccade latency. Each dot represents the mean saccade amplitude in a 50 ms time bin across all patients (purple) and controls (green). Vertical lines indicate SE. **p < 0.01; ***p < 0.001; ranked sum test.

View this table:
  • View inline
  • View popup
Table 2.

Saccadic eye-movement accuracy in pro- and anti-saccade task

View this table:
  • View inline
  • View popup
Table 3.

Saccadic eye-movement variability in pro- and anti-saccade task

In the pro-saccade task, saccade latencies ranged from 50 to 600 ms (Fig. 3E). Notably, patients made more express saccades with latencies shorter than 150 ms compared with controls (patients: 7.8%; controls: 1.7%). To investigate whether increased latency variability in patients could be linked to saccade accuracy, we analyzed saccade amplitude as a function of saccade latency at a group level. Overall, saccades were hypometric (inaccurate) in patients compared with controls for all latency intervals (p < 0.001 and z > 3.62 for all latencies <450 ms and p = 0.004 and z = 2.91 for latencies >450 ms). Interestingly, hypometric saccades in patients were particularly prominent at the shortest saccade latency interval (Fig. 3E). These results suggest that patients might have made reflexive saccades toward the cued target before motor planning was complete.

In the anti-saccade task, participants had to inhibit a saccade response to a cued distractor location and instead make a deliberate saccade to the opposite side (Fig. 4A). We assessed task performance by describing two types of errors: direction errors are defined as saccades that landed on the cued target location and were not subsequently corrected. Changes of mind are defined as saccades that were initially directed to the cued target location but then corrected to the opposite side. In patients and controls, the frequency of direction errors was lower than the frequency of changes of mind, indicating that most saccades that were initially directed at the cued distractor were subsequently corrected (Table 2). Overall, patients made about twice as many errors as controls, and were significantly more likely to change their mind compared with controls (Fig. 4B; Table 2).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Sequence of events and eye movements in the anti-saccade task. A, Each trial started with a drift correction followed by a fixation period. Participants had to saccade to the uncued target square. B, 2D eye position in pro-saccade task for a representative PD patient (purple) and control participant (green). For illustration purposes, eye and target position data were flipped to always depict the saccade target on the right. C, Saccade latency distributions (relative frequency of binned saccade latencies) for patients and controls. Blue bins represent changes of mind. Red bins represent direction errors. D, Task performance (percentage of saccades toward uncued location without any corrections) as a function of saccade latency. ***p < 0.001 (ranked sum test).

Similar to the pro-saccade task, we observed that patients had more variable eye movement amplitudes, velocities, and latencies across trials (within-participant variability) compared with controls (Table 3). We compared saccade kinematics for trials in which participants correctly performed the task (excluding trials with direction errors and changes of minds). As in the pro-saccade task, patients made slower saccades than controls (Table 2), but anti-saccades were overall of similar amplitude in both groups of participants (Fig. 4B). These findings indicate that hypometria might overall be less prevalent in a task that required more deliberation and triggered longer saccade latencies compared with a visually cued saccade task.

We next evaluated task performance (correct trials, direction errors, and changes of mind) as a function of saccade latency. Although patients initiated saccades at around the same time as controls (Table 2), their task performance depended on saccade latencies. Shorter saccade latencies were associated with more errors (Fig. 4C,D); indeed, patients only made more errors than controls for saccades with latencies <300 ms (p < 0.001 and z > 5.15). These findings mirror the observation that short-latency pro-saccades in patients tend to be hypometric and indicate that patients' saccade task performance in generally is most impaired for short-latency saccades.

To directly link performance in the pro- and anti-saccade task, we chose two measures that were indicative of performance in each task and were related to successful saccade inhibition. To measure performance in the pro-saccade task, we calculated the percentage of express saccades participants made toward the cued target, and the amplitude of all prosaccades. For the anti-saccade task, the performance measure was the frequency of task errors (direction errors and changes of mind). We then related the two performance measures across tasks. In the patient group, we found a positive correlation (r = 0.85) between express saccades in the pro-saccade task and error rate in the anti-saccade task (Fig. 5A). Similarly, we found that patients' pro-saccade amplitude was negatively related to the anti-saccade error rate (r = −0.80): patients whose pro-saccades were more hypometric on average also made more errors in the anti-saccade task (R2 = 0.64, p < 0.001). By contrast, no relationship between antisaccade error rate and either the frequency of express saccades or the amplitude of pro-saccades was found in the control group. Only one control participant (C57; a highly trained vision scientist who is one of the authors) initiated saccades with latencies shorter than 150 ms, but her task error rate was low. Comparing saccade latency distributions between C57 and a PD patient that had the same rate of express saccades (P35) illustrates a key difference. Whereas C57 has a narrow distribution of saccades centered around a latency of ∼175 ms, P35 has an initial distribution of express saccades that peaks at ∼75 ms and then another widespread distribution of longer-latency saccades (Fig. 5B). The observation that the rate of express saccades during the pro-saccade task was linked to the rate of errors during the anti-saccade task in PD patients suggests that eye movements to stationary targets are controlled similarly regardless of the level of movement deliberation.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Comparison of pro- and anti-saccade task performance. A, Relationship between the frequency of express saccades during the pro-saccade task and the error rate (saccade toward the cued target) in the anti-saccade task. Each circle represents a patient (purple) and control participant (green). Significant regression results in patient group: ***p < 0.001. B, Saccade distributions of a control participant (C57; green) and patient (P35; purple) who had a similar rate of express saccades.

Eye and hand movements to moving targets are preserved in PD patients

Participants performed two tasks that involved moving targets. In the sinusoidal pursuit task, participants were asked to follow a moving target with their eyes; in the go/no-go track-intercept task, participants had to follow and manually intercept a moving target that disappeared after brief initial presentation. In the sinusoidal pursuit task (Fig. 6A), we found that patients were able to track the moving target with similar speed and accuracy as controls (Fig. 6B). Although patients made more catch-up saccades on average to keep their eyes aligned with the moving target, patients' saccades during pursuit were as accurate as controls' (comparable position error), indicating that pursuit performance was overall preserved (Table 4).

View this table:
  • View inline
  • View popup
Table 4.

Eye movement accuracy during sinusoidal pursuit and track-intercept task

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Sequence of events and eye movements in sinusoidal pursuit task. A, Each trial started with a drift correction followed by five cycles of sinusoidal target motion in either horizontal or vertical direction. B, 2D eye position for a horizontally moving target at a speed of 16 deg/s for a representative PD patient (purple) and control participant (green). Saturated segments represent saccades. Lighter segments represent smooth pursuit.

During the go/no-go track-intercept task, participants viewed a moving target that disappeared after 300 or 500 ms before passing through or missing an indicated strike zone (Fig. 7A). In each trial, participants had to predict whether the no longer visible target would pass (go response required) or miss (no-go required). We first compared how well participants were able to track the moving target with their eyes while it was visible. Similar to sinusoidal pursuit, we found that patients' tracking was as fast and as accurate as controls' pursuit, with comparable eye velocity and position errors (Fig. 7B; Table 4). However, patients initiated smooth pursuit later and made their first catch-up saccade toward the target later than controls (Fig. 7C), indicating that patients showed less anticipation of predictable target motion. Notwithstanding these differences in eye movement timing, patients' go/no-go decision accuracy (i.e., correctly differentiating whether the target would hit or miss the strike zone) was similar to performance in controls (Mpatients = 79.2%, Mcontrols = 83.7%; t(27.7) = 1.12; p = 0.27; d = 0.41). Because we found performance differences as a function of saccade latency in our saccade tasks, we next analyzed go/no-go decision accuracy on a group level as a function of the first saccade latency. We find that patients have less early catch-up saccades compared with controls (Fig. 7C). However, congruent with findings in the pro-saccade and anti-saccade tasks, patients were relatively less accurate in their go/no-go decisions compared with controls when initial catch-up saccades were shorter than 150 ms (p = 0.004; z = 2.92).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Sequence of events and eye movements in go/no-go track-intercept task. A, Each trial started with a fixation period. Participants viewed a moving, disappearing target and had to judge whether the target would miss or pass a strike box. B, 2D eye position in track-intercept task for a representative PD patient (purple) and control participant (green). C, First catch-up saccade latency distributions (relative frequency of binned saccade latencies) for patients and controls. Red bins indicate trials in which the go/no-go decision was incorrect. D, Go/no-go decision accuracy as a function of initial catch-up saccade latency for patients (purple) and controls (green). Circles represent group mean for given saccade interval. **p < 0.01 (ranked sum test).

Hand movement deficits are compensated during track-intercept task

The go/no-go track-intercept task required a decision of whether to initiate or withhold a hand movement. Following a go-decision, participants had to move their hand to the strike box and intercept the moving target at the right time. A comparison of hand movement dynamics showed that patients moved their hand slower on average than controls (Fig. 8A). However, patients initiated their hand movement ∼150 ms earlier than controls (Table 5). Notwithstanding these differences in hand movement latency and velocity between patients and controls, both groups intercepted the target with a comparable timing error—100 ms too early on average (Fig. 8B)—and overshot the target location with the same average interception error (Table 5). These findings show that interception timing and accuracy are preserved in PD patients despite motor slowing.

View this table:
  • View inline
  • View popup
Table 5.

Hand movement kinematics during track-intercept task

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Hand movement dynamics in track-intercept task. A, Hand movement velocity across time for individual (thin lines) patients (purple) and controls (green). Thick lines indicate group average. B, Interception timing error for patients and controls. Positive timing errors indicate that participants intercepted too early; negative timing error indicates late interceptions.

Discussion

Oculomotor function is known to be systematically impaired in patients with PD. Here we argue against a general oculomotor decline and show instead that oculomotor deficits are strongly stimulus- and task-dependent. Our findings provide evidence for differential vulnerability for oculomotor responses to stationary versus moving stimuli. Different pathologic disease processes might underlie functional decline in response to different types of visual stimulation. In summary, we report the following key findings.

Patients showed systematic impairments when making saccades to stationary targets, regardless of whether the task required reactive pro-saccades or more deliberate anti-saccades. Patients' pro-saccades were hypometric and anti-saccades went in the wrong direction more frequently than for controls. Overall, patients had difficulties inhibiting reactive saccades to a cued target or distractor, leaving less time to complete accurate motor planning.

Patients did not show impairment when tracking a moving object using a combination of smooth pursuit and saccades. Although patients made more catch-up saccades than controls during sinusoidal pursuit, we did not observe any differences in eye position error or pursuit velocity gain. These results suggest that eye movements to moving stimuli are relatively preserved in PD. Congruently, we found that patients were able to accurately track and predict the trajectory of a moving target that disappeared after a brief viewing time. Go/no-go decision accuracy and timing were overall preserved in patients, except when they initiated a very early catch-up saccade toward the target, thereby limiting time for sensory evidence accumulation. Patients moved their hand slower than controls but were able to compensate by initiating their movements earlier, potentially indicating a learned adjustment to changes in motor function. Alternatively, a 150 ms decrease in mean hand movement latency in patients compared with controls could signify impulsivity, a common problem in PD patients (Corvol et al., 2018). In conjunction with this finding, patients also showed increased errors in the anti-saccade task, a potential early indicator of impulse control problems in these patients (Barbosa et al., 2019). It is therefore possible that patients moved their hand earlier simply because they could not wait to start the task.

Differential vulnerability to stationary versus dynamic visual stimulation

In recent years, saccade tasks have become a useful clinical tool to investigate the control and inhibition of eye movements toward visual stimuli in psychiatric and neurologic patient populations (Everling and Fischer, 1998; Hutton and Ettinger, 2006; Patel et al., 2019). In PD, saccades toward stationary (visual or remembered) targets are hypometric (Rottach et al., 1996; Gurvich et al., 2007; Helmchen et al., 2012), presumably because of excessive superior colliculus inhibition (Terao et al., 2011). In anti-saccade tasks, patients make more incorrect saccades toward the distractor and exhibit a higher saccade latency than controls (Briand et al., 1999; Chan et al., 2005; Amador et al., 2006; for review, see Waldthaler et al., 2021). Our study adds to these findings by showing that task-specific errors (hypometric pro-saccades, incorrect anti-saccades) occurred predominantly in short-latency saccades. We interpret this finding as evidence of incomplete motor planning: if a saccade is made early, there is less time for accurate direction and endpoint planning (Viviani and Swensson, 1982; Findlay, 1983; Cameron et al., 2012). Both the increase in error rate in the anti-saccade task and the increase in express saccades during the pro-saccade task suggest that PD patients demonstrate decreased inhibitory control (for across-task dependencies, see also Ouerfelli-Ethier et al., 2018), possibly in conjunction with decreased impulse control (Bari and Robbins, 2013). Deficits in inhibitory control might not only be related to impairments in oculomotor pathways but could also be the consequence of adaptive motor control. To counteract slow movement initiation (commonly observed in PD patients), the oculomotor system might reduce baseline response inhibition (Chan et al., 2005). Here we show that PD patients initiated an interceptive hand movement toward a moving target earlier than controls. As one possible explanation, these findings suggest long-term adaptive mechanisms that could be related to an altered baseline response inhibition.

An impairment of movement toward stationary targets is also observed during reaching. Whereas PD patients exhibited bradykinesia when reaching for a stationary object, they moved as fast as controls and with comparable accuracy when reaching for a moving object (Majsak et al., 1998, 2008). These studies highlight the importance of considering movement requirements and time constraints in oculomotor and sensorimotor control (Goettker and Gegenfurtner, 2021). Whereas reaches to stationary objects required a fast but self-determined movement, dynamic objects rolled rapidly toward a contact zone, providing an external cue for urgent reaches. The authors conclude that internally regulated movements are more impaired in PD patients than externally stimulated movements. Accordingly, PD patients showed similar eye and hand movements as controls during our track-intercept task, which required urgent interceptive movements toward a designated strike zone. The task incorporated an external movement cue (the strike zone) and visual performance feedback, additional factors that might have facilitated preservation of function. Eye movements were also preserved in our sinusoidal pursuit task, which required no urgency or deliberation similar to previous studies that tested simple ramp-pursuit tasks (Fukushima et al., 2015). These findings indicate that providing external stimulation, either through a task-evoked sense of urgency and temporal movement cues or through continuous stimulus presentation, is associated with preservation of eye and hand movements function in PD patients.

Is sensorimotor prediction impaired in PD patients?

When interacting with moving objects, it is critical to accurately predict the sensory outcome of visual events (Fiehler et al., 2019). We tested participants in two tasks involving moving stimuli that required different levels of prediction. In the sinusoidal pursuit task, participants tracked a moving target that moved continuously and predictably. In the track-intercept task, participants had to extrapolate the target's trajectory after it had disappeared, requiring deliberate eye movements and interception at a predicted location. In both tasks, we found relative preservation of pursuit velocity and position error as well as preserved predictive ability to guide an interceptive hand movement.

By contrast, smooth pursuit had been shown to be impaired in task conditions that required integrating cue information or anticipation. When remembering the meaning of two consecutive cues (one direction cue and one go/no-go cue), PD patients tended to track the target using saccades rather than following it smoothly (Fukushima et al., 2015). Internally generated or predictive movements were also impaired in studies using anticipatory pursuit in response to a target direction reversal (de Hemptinne et al., 2013) or target blanking (Helmchen et al., 2012), or when testing the accuracy of manually controlling a randomly moving target by using a joystick (Chen et al., 2016). These studies provide converging evidence that PD patients lose the ability to move in anticipation of a future visual event when tasks require concentration and effort but no implied urgency to move. In contrast, the combination of an externally provided end location and a time-critical movement constraint (Majsak et al., 1998, 2008; Fooken and Spering, 2019, 2020) can facilitate the preservation of predictive abilities in PD patients.

Brain networks underlying differential impairments in PD patients

Different levels of functional impairments in response to different types of visual stimulation have also been observed in healthy aging. For example, a study investigating motion perception in a large sample of healthy adults across the lifespan (Billino et al., 2008) found preserved ability to perceive complex motion patterns (biological motion and radial motion) compared with simpler ones (translational motion). The authors speculate that motion stimuli with high ecological relevance (e.g., expanding radial flow might induce a fight or flight response) might be processed more efficiently, and potentially by a set of functional pathways that bypass primary visual cortex. Studies that found dissociations between motion perception and smooth pursuit eye movements have similarly argued that the pursuit system could be aided by a separate subcortical pathway that forms a direct connection from the retina to superior colliculus and brainstem (Spering and Carrasco, 2015).

Stimulus-dependent preservation and impairments of movements in PD are in accordance with the idea of different functional pathways. Dysfunction of the fronto-basal ganglia network might be linked to impaired inhibitory control of action planning and deliberation (Alexander and Crutcher, 1990; Mink, 1996; Brown et al., 2004; Aron et al., 2007; Lalo et al., 2008; Wiecki and Frank, 2010). Preserved fast visuomotor responses, such as manual interceptions, and visually guided eye movements might be associated with superior colliculus-brainstem loops (Corneil and Munoz, 2014) and the tecto-reticulo-spinal pathway (Gu et al., 2016). Preservation of oculomotor function in PD could also be mediated by a direct pathway, bypassing dopaminergic connections through the basal ganglia (Basso et al., 2005) or a hyperdirect pathway linking cortical eye movement areas to the subthalamic nucleus of the basal ganglia (Nambu et al., 2002; Sieger et al., 2013). The subthalamic nucleus is involved in pursuit and saccadic eye movement control and is a target area for deep brain stimulation in PD patients (FitzGerald and Antoniades, 2016; Lee et al., 2019).

Movement preservation and impairment in response to different types of stimuli and temporal task constraints might also be related to task motivation. Previous research has linked bradykinesia in PD to a lack of movement motivation (Mazzoni et al., 2007). When patients were given feedback about their movement speed, they were able to point to a stationary target as fast and accurately as age-matched control. However, PD patients implicitly chose to move at a slower speed compared with controls and needed more repetitions to attain the desired number of valid (sufficiently fast) trials. The authors propose that impaired movement motivation is linked to dopaminergic projections from the midbrain to the striatum (Mazzoni et al., 2007; Niv et al., 2007; Schultz, 2007; Moustafa et al., 2008). Dopaminergic medication enhanced the ability of PD patients to anticipate error signals when continuously tracking an unpredictably moving visual target with a joystick (Chen et al., 2016), indicating that dopamine increases sensitivity to positive reinforcement learning processes (Frank et al., 2004). In our tasks, we did not find systematic effects of dopaminergic medication on eye or hand movements. These findings are consistent with other studies showing comparable smooth pursuit eye movements in patients on and off medication (Ladda et al., 2008; Cameron et al., 2012; Fukushima et al., 2015; but see Hood et al., 2007). Congruently, a recent meta-analysis found that levodopa administration does not impact anti-saccade latency and error rate (Waldthaler et al., 2021; see also Lu et al., 2019). In our study, ON medication visits were scheduled at any time of the day, whereas OFF medication visits were always scheduled in the morning to reduce discomfort from being off medication for too long. There is a small chance that the benefit of being tested in the morning might have partly outweighed the cost of not being on medication. However, results from one unmedicated patient (P23) were comparable to the average performance of our patient group. Therefore, it is possible that dopaminergic medication does not mitigate oculomotor impairments that are already observed in drug-naive PD patients at an early stage of the disease (Antoniades et al., 2015). Effects of pharmacological treatment in PD, which often includes nondopaminergic drugs, such as antidepressants, need to be further investigated in larger samples of patients and longitudinally across disease stages (Reilly et al., 2008). Of note, newer treatments, such as deep brain stimulation, potentially offer alleviation of smooth pursuit and saccade performance as well as an avenue toward understanding the foundations of oculomotor dysfunction in PD (FitzGerald and Antoniades, 2016).

In conclusion, the present study provides evidence for stimulus- and task-dependent oculomotor deficits in PD patients. Systematic impairments of saccades to stationary targets at short latencies indicate impaired inhibitory oculomotor control in PD patients. In turn, the relative preservation of visually guided smooth pursuit, motion prediction, and fast manual interception might be mediated by separate functional pathways rather than differences in movement motivation. Our findings can inform the development of tasks that are engaging and motivating for functional training in PD patients. Furthermore, we found evidence for adaptive mechanisms in the eye (decreased inhibition to compensate increased latency) and in the hand (decreased latency to compensate decreased velocity). Such long-term sensorimotor adaptation might be related to continuous reinforcement that patients receive during everyday life.

Footnotes

  • This work was supported by Deutsche Forschungsgemeinschaft Research Fellowships Grant FO 1347/1-1 to J.F.; and Natural Sciences and Engineering Research Council Discovery Grant and Accelerator Supplement to M.S. We thank Kiran Mann for help with data collection; and Doris Chow for feedback on the manuscript.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Jolande Fooken at jolande.fooken{at}queensu.ca

SfN exclusive license.

References

  1. ↵
    1. Albin RL,
    2. Young AB,
    3. Penney JB
    (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366–375. doi:10.1016/0166-2236(89)90074-x pmid:2479133
    OpenUrlCrossRefPubMed
  2. ↵
    1. Alexander GE,
    2. Crutcher MD
    (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266–271. doi:10.1016/0166-2236(90)90107-l pmid:1695401
    OpenUrlCrossRefPubMed
  3. ↵
    1. Amador S,
    2. Hood A,
    3. Schiess M,
    4. Izor R,
    5. Sereno A
    (2006) Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients. Neuropsychologia 44:1475–1482. doi:10.1016/j.neuropsychologia.2005.11.015 pmid:16376954
    OpenUrlCrossRefPubMed
  4. ↵
    1. Antoniades CA,
    2. Demeyere N,
    3. Kennard C,
    4. Humphreys GW,
    5. Hu MT
    (2015) Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: the discovery study. Mov Disord 30:843–847. doi:10.1002/mds.26134 pmid:25600361
    OpenUrlCrossRefPubMed
  5. ↵
    1. Armstrong RA
    (2008) Visual signs and symptoms of Parkinson's disease. Clin Exp Optom 91:129–138. doi:10.1111/j.1444-0938.2007.00211.x pmid:18271776
    OpenUrlCrossRefPubMed
  6. ↵
    1. Armstrong RA
    (2015) Oculo-visual dysfunction in Parkinson's disease. J Parkinsons Dis 5:715–726. doi:10.3233/JPD-150686 pmid:26599301
    OpenUrlCrossRefPubMed
  7. ↵
    1. Aron AR,
    2. Durston S,
    3. Eagle DM,
    4. Logan GD,
    5. Stinear CM,
    6. Stuphorn V
    (2007) Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci 27:11860–11864. doi:10.1523/JNEUROSCI.3644-07.2007 pmid:17978025
    OpenUrlFREE Full Text
  8. ↵
    1. Barbosa P,
    2. Kaski D,
    3. Castro P,
    4. Lees AJ,
    5. Warner TT,
    6. Djamshidian A
    (2019) Saccadic direction errors are associated with impulsive compulsive behaviours in Parkinson's disease patients. J Parkinsons Dis 9:625–630. doi:10.3233/JPD-181460 pmid:31282422
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bari A,
    2. Robbins TW
    (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44–79. doi:10.1016/j.pneurobio.2013.06.005 pmid:23856628
    OpenUrlCrossRefPubMed
  10. ↵
    1. Basso MA,
    2. Pokorny JJ,
    3. Liu P
    (2005) Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys: basal ganglia and pursuit. Eur J Neurosci 22:448–464. doi:10.1111/j.1460-9568.2005.04215.x pmid:16045498
    OpenUrlCrossRefPubMed
  11. ↵
    1. Bhutani N,
    2. Sureshbabu R,
    3. Farooqui AA,
    4. Behari M,
    5. Goyal V,
    6. Murthy A
    (2013) Queuing of concurrent movement plans by basal ganglia. J Neurosci 33:9985–9997. doi:10.1523/JNEUROSCI.4934-12.2013 pmid:23761894
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Billino J,
    2. Bremmer F,
    3. Gegenfurtner KR
    (2008) Differential aging of motion processing mechanisms: evidence against general perceptual decline. Vision Res 48:1254–1261. doi:10.1016/j.visres.2008.02.014 pmid:18396307
    OpenUrlCrossRefPubMed
  13. ↵
    1. Brainard DH
    (1997) The Psychophysics Toolbox. Spat Vis 10:433–436. pmid:9176952
    OpenUrlCrossRefPubMed
  14. ↵
    1. Briand KA,
    2. Strallow D,
    3. Hening W,
    4. Poizner H,
    5. Sereno AB
    (1999) Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 129:38–48. doi:10.1007/s002210050934 pmid:10550501
    OpenUrlCrossRefPubMed
  15. ↵
    1. Brown JW,
    2. Bullock D,
    3. Grossberg S
    (2004) How laminar frontal cortex and basal ganglia circuits interact to control planned and reactive saccades. Neural Netw 17:471–510. doi:10.1016/j.neunet.2003.08.006 pmid:15109680
    OpenUrlCrossRefPubMed
  16. ↵
    1. Cameron IG,
    2. Pari G,
    3. Alahyane N,
    4. Brien DC,
    5. Coe BC,
    6. Stroman PW,
    7. Munoz DP
    (2012) Impaired executive function signals in motor brain regions in Parkinson's disease. Neuroimage 60:1156–1170. doi:10.1016/j.neuroimage.2012.01.057 pmid:22270353
    OpenUrlCrossRefPubMed
  17. ↵
    1. Chan F,
    2. Armstrong IT,
    3. Pari G,
    4. Riopelle RJ,
    5. Munoz DP
    (2005) Deficits in saccadic eye-movement control in Parkinson's disease. Neuropsychologia 43:784–796. doi:10.1016/j.neuropsychologia.2004.06.026 pmid:15721191
    OpenUrlCrossRefPubMed
  18. ↵
    1. Chen J,
    2. Ho SL,
    3. Lee TM,
    4. Chang RS,
    5. Pang SY,
    6. Li L
    (2016) Visuomotor control in patients with Parkinson's disease. Neuropsychologia 80:102–114. doi:10.1016/j.neuropsychologia.2015.10.036 pmid:26529488
    OpenUrlCrossRefPubMed
  19. ↵
    1. Corneil BD,
    2. Munoz DP
    (2014) Overt responses during covert orienting. Neuron 82:1230–1243. doi:10.1016/j.neuron.2014.05.040 pmid:24945769
    OpenUrlCrossRefPubMed
  20. ↵
    1. Corvol JC,
    2. Artaud F,
    3. Cormier-Dequaire F,
    4. Rascol O,
    5. Durif F,
    6. Derkinderen P,
    7. Marques AR,
    8. Bourdain F,
    9. Brandel JP,
    10. Pico F,
    11. Lacomblez L,
    12. Bonnet C,
    13. Brefel-Courbon C,
    14. Ory-Magne F,
    15. Grabli D,
    16. Klebe S,
    17. Mangone G,
    18. You H,
    19. Mesnage V,
    20. Lee PC, et al
    . (2018) Longitudinal analysis of impulse control disorders in Parkinson disease. Neurol 91:e189–e201. doi:10.1212/WNL.0000000000005816 pmid:29925549
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. de Hemptinne C,
    2. Ivanoiu A,
    3. Lefèvre P,
    4. Missal M
    (2013) How does Parkinson's disease and aging affect temporal expectation and the implicit timing of eye movements? Neuropsychologia 51:340–348. doi:10.1016/j.neuropsychologia.2012.10.001 pmid:23063965
    OpenUrlCrossRefPubMed
  22. ↵
    1. Desmurget M,
    2. Gaveau V,
    3. Vindras P,
    4. Turner RS,
    5. Broussolle E,
    6. Thobois S
    (2004) On-Line motor control in patients with Parkinson's disease. Brain 127:1755–1773. doi:10.1093/brain/awh206 pmid:15215215
    OpenUrlCrossRefPubMed
  23. ↵
    1. Duysens J,
    2. Nonnekes J
    (2021) Parkinson's kinesia paradoxa is not a paradox. Mov Disord 36:1115–1118. doi:10.1002/mds.28550 pmid:33656203
    OpenUrlCrossRefPubMed
  24. ↵
    1. Everling S,
    2. Fischer B
    (1998) The antisaccade: a review of basic research and clinical studies. Neuropsychologia 36:885–899. doi:10.1016/s0028-3932(98)00020-7 pmid:9740362
    OpenUrlCrossRefPubMed
  25. ↵
    1. Fiehler K,
    2. Brenner E,
    3. Spering M
    (2019) Prediction in goal-directed action. J Vis 19:1–21.
    OpenUrlCrossRef
  26. ↵
    1. Findlay JM
    (1983) Visual information processing for saccadic eye movements. In: Spatially oriented behavior (Hein A, Jeannerod M, eds), pp 281–303. New York: Springer.
  27. ↵
    1. Fischer B
    (1987) The preparation of visually guided saccades. Rev Physiol Biochem Pharmacol 106:1–35. doi:10.1007/BFb0027574 pmid:3112911
    OpenUrlCrossRefPubMed
  28. ↵
    1. FitzGerald JJ,
    2. Antoniades CA
    (2016) Eye movements and deep brain stimulation. Curr Opin Neurol 29:69–73. doi:10.1097/WCO.0000000000000276 pmid:26641812
    OpenUrlCrossRefPubMed
  29. ↵
    1. Fooken J,
    2. Spering M
    (2019) Decoding go/no-go decisions from eye movements. J Vis 19:1–13.
    OpenUrlCrossRef
  30. ↵
    1. Fooken J,
    2. Spering M
    (2020) Eye movements as a readout of sensorimotor decision processes. J Neurophysiol 123:1439–1447. doi:10.1152/jn.00622.2019 pmid:32159423
    OpenUrlCrossRefPubMed
  31. ↵
    1. Frank MJ,
    2. Seeberger LC,
    3. O'Reilly RC
    (2004) By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science 306:1940–1943. doi:10.1126/science.1102941 pmid:15528409
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Fukushima K,
    2. Ito N,
    3. Barnes GR,
    4. Onishi S,
    5. Kobayashi N,
    6. Takei H,
    7. Olley PM,
    8. Chiba S,
    9. Inoue K,
    10. Warabi T
    (2015) Impaired smooth pursuit in Parkinson's disease: normal cue information memory, but dysfunction of extraretinal mechanisms for pursuit preparation and execution. Physiol Rep 3:e12361. doi:10.14814/phy2.12361
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Fukushima K,
    2. Fukushima J,
    3. Barnes GR
    (2017) Clinical application of eye movement tasks as an aid to understanding Parkinson's disease pathophysiology. Exp Brain Res 235:1309–1321. doi:10.1007/s00221-017-4916-5 pmid:28258438
    OpenUrlCrossRefPubMed
  34. ↵
    1. Gallea C,
    2. Wicki B,
    3. Ewenczyk C,
    4. Rivaud-Péchoux S,
    5. Yahia-Cherif L,
    6. Pouget P,
    7. Vidailhet M,
    8. Hainque E
    (2021) Antisaccade, a predictive marker for freezing of gait in Parkinson's disease and gait/gaze network connectivity. Brain 144:504–514. doi:10.1093/brain/awaa407 pmid:33279957
    OpenUrlCrossRefPubMed
  35. ↵
    1. Glickstein M,
    2. Stein J
    (1991) Paradoxical movement in Parkinson's disease. Trends Neurosci 14:480–482. doi:10.1016/0166-2236(91)90055-y pmid:1726761
    OpenUrlCrossRefPubMed
  36. ↵
    1. Goettker A,
    2. Gegenfurtner KR
    (2021) A change in perspective: the interaction of saccadic and pursuit eye movements in oculomotor control and perception. Vision Res 188:283–296. doi:10.1016/j.visres.2021.08.004 pmid:34489101
    OpenUrlCrossRefPubMed
  37. ↵
    1. Goetz CG,
    2. Poewe W,
    3. Rascol O,
    4. Sampaio C,
    5. Stebbins GT,
    6. Counsell C,
    7. Giladi N,
    8. Holloway RG,
    9. Moore CG,
    10. Wenning GK,
    11. Yahr MD,
    12. Seidl L
    , Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028. doi:10.1002/mds.20213 pmid:15372591
    OpenUrlCrossRefPubMed
  38. ↵
    1. Gu C,
    2. Wood DK,
    3. Gribble PL,
    4. Corneil BD
    (2016) A trial-by-trial window into sensorimotor transformations in the human motor periphery. J Neurosci 36:8273–8282. doi:10.1523/JNEUROSCI.0899-16.2016 pmid:27488645
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Gurvich C,
    2. Georgiou-Karistianis N,
    3. Fitzgerald PB,
    4. Millist L,
    5. White OB
    (2007) Inhibitory control and spatial working memory in Parkinson's disease. Mov Disord 22:1444–1450. doi:10.1002/mds.21510 pmid:17516454
    OpenUrlCrossRefPubMed
  40. ↵
    1. Helmchen C,
    2. Pohlmann J,
    3. Trillenberg P,
    4. Lencer R,
    5. Graf J,
    6. Sprenger A
    (2012) Role of anticipation and prediction in smooth pursuit eye movement control in Parkinson's disease. Mov Disord 27:1012–1018. doi:10.1002/mds.25042 pmid:22693071
    OpenUrlCrossRefPubMed
  41. ↵
    1. Hikosaka O,
    2. Takikawa Y,
    3. Kawagoe R
    (2000) Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80:953–978. doi:10.1152/physrev.2000.80.3.953 pmid:10893428
    OpenUrlCrossRefPubMed
  42. ↵
    1. Hood AJ,
    2. Amador SC,
    3. Cain AE,
    4. Briand KA,
    5. Al-Refai AH,
    6. Schiess MC,
    7. Sereno AB
    (2007) Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease. J Neurol Neurosurg Psychiatry 78:565–570. doi:10.1136/jnnp.2006.099754 pmid:17178817
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Hutton SB,
    2. Ettinger U
    (2006) The antisaccade task as a research tool in psychopathology: a critical review. J Psychophysiol 43:302–313. doi:10.1111/j.1469-8986.2006.00403.x pmid:16805870
    OpenUrlCrossRefPubMed
  44. ↵
    1. Jenkinson N,
    2. Brown P
    (2011) New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci 34:611–618. doi:10.1016/j.tins.2011.09.003 pmid:22018805
    OpenUrlCrossRefPubMed
  45. ↵
    1. Kleiner M,
    2. Brainard D,
    3. Pelli D,
    4. Ingling A,
    5. Murray R,
    6. Broussard C
    (2007) What's new in Psychtoolbox-3? Perception 36:1–16.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Ladda J,
    2. Valkovič P,
    3. Eggert T,
    4. Straube A
    (2008) Parkinsonian patients show impaired predictive smooth pursuit. J Neurol 255:1071–1078. doi:10.1007/s00415-008-0852-4 pmid:18438696
    OpenUrlCrossRefPubMed
  47. ↵
    1. Lalo E,
    2. Thobois S,
    3. Sharott A,
    4. Polo G,
    5. Mertens P,
    6. Pogosyan A,
    7. Brown P
    (2008) Patterns of bidirectional communication between cortex and basal ganglia during movement in patients with Parkinson disease. J Neurosci 28:3008–3016. doi:10.1523/JNEUROSCI.5295-07.2008
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Lee S,
    2. Liu A,
    3. Wang ZJ,
    4. McKeown MJ
    (2019) Abnormal phase coupling in Parkinson's disease and normalization effects of subthreshold vestibular stimulation. Front Hum Neurosci 13:118. doi:10.3389/fnhum.2019.00118 pmid:31001099
    OpenUrlCrossRefPubMed
  49. ↵
    1. Leigh RJ,
    2. Zee DS
    (2015) The neurology of eye movements. Oxford, UK: Oxford UP.
  50. ↵
    1. Lu Z,
    2. Buchanan T,
    3. Kennard C,
    4. FitzGerald JJ,
    5. Antoniades CA
    (2019) The effect of levodopa on saccades: Oxford Quantification in Parkinsonism Study. Parkinsonism Relat Disord 68:49–56. doi:10.1016/j.parkreldis.2019.09.029 pmid:31621619
    OpenUrlCrossRefPubMed
  51. ↵
    1. Majsak MJ,
    2. Kaminski T,
    3. Gentile AM,
    4. Flanagan JR
    (1998) The reaching movements of patients with Parkinson's disease under self-determined maximal speed and visually cued conditions. Brain 121:755–766. doi:10.1093/brain/121.4.755
    OpenUrlCrossRefPubMed
  52. ↵
    1. Majsak MJ,
    2. Kaminski T,
    3. Gentile AM,
    4. Gordon AM
    (2008) Effects of a moving target versus a temporal constraint on reach and grasp in patients with Parkinson's disease. Exp Neurol 210:479–488. doi:10.1016/j.expneurol.2007.11.023 pmid:18237731
    OpenUrlCrossRefPubMed
  53. ↵
    1. Marx S,
    2. Respondek G,
    3. Stamelou M,
    4. Dowiasch S,
    5. Stoll J,
    6. Bremmer F,
    7. Oertel WH,
    8. Höglinger GU,
    9. Einhäuser W
    (2012) Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease. Front Behav Neurosci 6:1–11.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Mazzoni P,
    2. Hristova A,
    3. Krakauer JW
    (2007) Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation. J Neurosci 27:7105–7116. doi:10.1523/JNEUROSCI.0264-07.2007 pmid:17611263
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. McNab F,
    2. Klingberg T
    (2008) Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci 11:103–107. doi:10.1038/nn2024 pmid:18066057
    OpenUrlCrossRefPubMed
  56. ↵
    1. Merritt KE,
    2. Seergobin KN,
    3. Mendonça DA,
    4. Jenkins ME,
    5. Goodale MA,
    6. MacDonald PA
    (2017) Automatic online motor control is intact in Parkinson's disease with and without perceptual awareness. eNeuro 4:ENEURO.0215-17.2017–12. doi:10.1523/ENEURO.0215-17.2017
    OpenUrlCrossRef
  57. ↵
    1. Ming W,
    2. Palidis DJ,
    3. Spering M,
    4. McKeown MJ
    (2016) Visual contrast sensitivity in early-stage Parkinson's disease. Invest Ophthalmol Vis Sci 57:5696–5704. doi:10.1167/iovs.16-20025 pmid:27784075
    OpenUrlCrossRefPubMed
  58. ↵
    1. Mink JW
    (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50:381–425. doi:10.1016/s0301-0082(96)00042-1 pmid:9004351
    OpenUrlCrossRefPubMed
  59. ↵
    1. Moustafa AA,
    2. Cohen MX,
    3. Sherman SJ,
    4. Frank MJ
    (2008) A role for dopamine in temporal decision making and reward maximization in Parkinsonism. J Neurosci 28:12294–12304. doi:10.1523/JNEUROSCI.3116-08.2008 pmid:19020023
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Munoz DP,
    2. Everling S
    (2004) Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218–228. doi:10.1038/nrn1345 pmid:14976521
    OpenUrlCrossRefPubMed
  61. ↵
    1. Nambu A,
    2. Tokuno H,
    3. Takada M
    (2002) Functional significance of the cortico–subthalamo–pallidal 'hyperdirect' pathway. Neurosci Res 43:111–117. doi:10.1016/s0168-0102(02)00027-5 pmid:12067746
    OpenUrlCrossRefPubMed
  62. ↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bédirian V,
    4. Charbonneau S,
    5. Whitehead V,
    6. Collin I,
    7. Cummings JL,
    8. Chertkow H
    (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. doi:10.1111/j.1532-5415.2005.53221.x pmid:15817019
    OpenUrlCrossRefPubMed
  63. ↵
    1. Niv Y,
    2. Daw ND,
    3. Joel D,
    4. Dayan P
    (2007) Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) 191:507–520. doi:10.1007/s00213-006-0502-4 pmid:17031711
    OpenUrlCrossRefPubMed
  64. ↵
    1. Noorani I,
    2. Carpenter RH
    (2014) Basal ganglia: racing to say no. Trends Neurosci 37:467–469. doi:10.1016/j.tins.2014.07.003 pmid:25131358
    OpenUrlCrossRefPubMed
  65. ↵
    1. Ouerfelli-Ethier J,
    2. Elsaeid B,
    3. Desgroseilliers J,
    4. Munoz DP,
    5. Blohm G,
    6. Khan AZ
    (2018) Anti-saccades predict cognitive functions in older adults and patients with Parkinson's disease. PLoS One 13:e0207589. doi:10.1371/journal.pone.0207589
    OpenUrlCrossRef
  66. ↵
    1. Patel S,
    2. Fitzgerald JJ,
    3. Antoniades CA
    (2019) Oculomotor effects of medical and surgical treatments of Parkinson's disease. Prog Brain Res 249:297–305. doi:10.1016/bs.pbr.2019.04.020 pmid:31325988
    OpenUrlCrossRefPubMed
  67. ↵
    1. Pelli DG
    (1997) The VideoToolbox software for visual psychophysics: transforming numbers into movies. Spat Vis 10:437–442. pmid:9176953
    OpenUrlCrossRefPubMed
    1. Perugini A,
    2. Ditterich J,
    3. Basso MA
    (2016) Patients with Parkinson's disease show impaired use of priors in conditions of sensory uncertainty. Curr Biol 26:1902–1910. doi:10.1016/j.cub.2016.05.039 pmid:27322000
    OpenUrlCrossRefPubMed
  68. ↵
    1. Perugini A,
    2. Ditterich J,
    3. Shaikh AG,
    4. Knowlton BJ,
    5. Basso MA
    (2018) Paradoxical decision-making: a framework for understanding cognition in Parkinson's disease. Trends Neurosci 41:512–525. doi:10.1016/j.tins.2018.04.006 pmid:29747856
    OpenUrlCrossRefPubMed
  69. ↵
    R Core Team (2017) R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
  70. ↵
    1. Reilly JL,
    2. Lencer R,
    3. Bishop JR,
    4. Keedy S,
    5. Sweeney JA
    (2008) Pharmacological treatment effects on eye movement control. Brain Cogn 68:415–435. doi:10.1016/j.bandc.2008.08.026 pmid:19028266
    OpenUrlCrossRefPubMed
  71. ↵
    1. Rottach KG,
    2. Riley DE,
    3. DiScenna AO,
    4. Zivotofsky AZ,
    5. Leigh RJ
    (1996) Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol 39:368–377. doi:10.1002/ana.410390314 pmid:8602756
    OpenUrlCrossRefPubMed
  72. ↵
    1. Schultz W
    (2007) Multiple dopamine functions at different time courses. Annu Rev Neurosci 30:259–288. doi:10.1146/annurev.neuro.28.061604.135722 pmid:17600522
    OpenUrlCrossRefPubMed
  73. ↵
    1. Schütz AC,
    2. Braun DI,
    3. Gegenfurtner KR
    (2011) Eye movements and perception: a selective review. J Vis 11:9. doi:10.1167/11.5.9
    OpenUrlCrossRefPubMed
  74. ↵
    1. Sieger T,
    2. Bonnet C,
    3. Serranová T,
    4. Wild J,
    5. Novák D,
    6. Růžička F,
    7. Urgošík D,
    8. Růžička E,
    9. Gaymard B,
    10. Jech R
    (2013) Basal ganglia neuronal activity during scanning eye movements in Parkinson's disease. PLoS One 8:e78581. doi:10.1371/journal.pone.0078581
    OpenUrlCrossRefPubMed
  75. ↵
    1. Spering M,
    2. Carrasco M
    (2015) Acting without seeing: eye movements reveal visual processing without awareness. Trends Neurosci 38:247–258. doi:10.1016/j.tins.2015.02.002 pmid:25765322
    OpenUrlCrossRefPubMed
  76. ↵
    1. Stuart S,
    2. Lawson RA,
    3. Yarnall AJ,
    4. Nell J,
    5. Alcock L,
    6. Duncan GW,
    7. Khoo TK,
    8. Barker RA,
    9. Rochester L,
    10. Burn DJ
    , ICICLE-PD Study Group (2019) Pro-saccades predict cognitive decline in Parkinson's disease: ICICLE-PD. Mov Disord 34:1690–1698. doi:10.1002/mds.27813 pmid:31442355
    OpenUrlCrossRefPubMed
  77. ↵
    1. Terao Y,
    2. Fukuda H,
    3. Yugeta A,
    4. Hikosaka O,
    5. Nomura Y,
    6. Segawa M,
    7. Hanajima R,
    8. Tsuji S,
    9. Ugawa Y
    (2011) Initiation and inhibitory control of saccades with the progression of Parkinson's disease: changes in three major drives converging on the superior colliculus. Neuropsychologia 49:1794–1806. doi:10.1016/j.neuropsychologia.2011.03.002 pmid:21420990
    OpenUrlCrossRefPubMed
  78. ↵
    1. Thura D,
    2. Cisek P
    (2017) The basal ganglia do not select reach targets but control the urgency of commitment. Neuron 95:1160–1170. doi:10.1016/j.neuron.2017.07.039 pmid:28823728
    OpenUrlCrossRefPubMed
  79. ↵
    1. Viviani P,
    2. Swensson RG
    (1982) Saccadic eye movements to peripherally discriminated visual targets. J Exp Psychol Hum Percept Perf 8:113–126. doi:10.1037/0096-1523.8.1.113
    OpenUrlCrossRefPubMed
  80. ↵
    1. Waldthaler J,
    2. Stock L,
    3. Student J,
    4. Sommerkorn J,
    5. Dowiasch S,
    6. Timmermann L
    (2021) Antisaccades in Parkinson's disease: a meta-analysis. Neuropsychol Rev 31:628–642. doi:10.1007/s11065-021-09489-1
    OpenUrlCrossRef
  81. ↵
    1. Wiecki TV,
    2. Frank MJ
    (2010) Neurocomputational models of motor and cognitive deficits in Parkinson's disease. Prog Brain Res 183:275–297. doi:10.1016/S0079-6123(10)83014-6 pmid:20696325
    OpenUrlCrossRefPubMed
  82. ↵
    1. Zokaei N,
    2. Gillebert CR,
    3. Chauvin JJ,
    4. Gresch D,
    5. Board AG,
    6. Rolinski M,
    7. Hu MT,
    8. Nobre AC
    (2021) Temporal orienting in Parkinson's disease. Eur J Neurosci 53:2713–2725. doi:10.1111/ejn.15114 pmid:33450082
    OpenUrlCrossRefPubMed
View Abstract
Back to top

In this issue

The Journal of Neuroscience: 42 (3)
Journal of Neuroscience
Vol. 42, Issue 3
19 Jan 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific
Jolande Fooken, Pooja Patel, Christina B. Jones, Martin J. McKeown, Miriam Spering
Journal of Neuroscience 19 January 2022, 42 (3) 487-499; DOI: 10.1523/JNEUROSCI.1690-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific
Jolande Fooken, Pooja Patel, Christina B. Jones, Martin J. McKeown, Miriam Spering
Journal of Neuroscience 19 January 2022, 42 (3) 487-499; DOI: 10.1523/JNEUROSCI.1690-21.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • eye movements
  • Parkinson's disease
  • prediction
  • preservation of function
  • saccades
  • smooth pursuit

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • Contributions of distinct attention mechanisms to saccadic choices in a gamified, dynamic environment
  • Functional near-infrared spectroscopy reveals functional rewiring between macaque motor areas following post-infarction recovery of manual dexterity
  • Bias in Visual Short-Term Memory for Motion Induced by Perceptually Suppressed Distractors
Show more Research Articles

Behavioral/Cognitive

  • Contributions of distinct attention mechanisms to saccadic choices in a gamified, dynamic environment
  • Functional near-infrared spectroscopy reveals functional rewiring between macaque motor areas following post-infarction recovery of manual dexterity
  • Bias in Visual Short-Term Memory for Motion Induced by Perceptually Suppressed Distractors
Show more Behavioral/Cognitive
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.